Conférence de consensus. Stratégies Thérapeutiques à long terme dans les psychoses schizophréniques, 1994. ,
La Schizophrénie de l'adulte. Des causes aux traitements, 2006. ,
Conférence de consensus Schizophrénies débutantes :diagnostic et modalités thérapeutiques ,
CIM-10/ICD-10, Classification Internationale des Troubles Mentaux et des Troubles du Comportement. Descriptions Cliniques et Directives pour le Diagnostic, 1993. ,
Critères diagnostiques Traduction française par, 2000. ,
Epidemiology of Schizophrenia: A European Perspective, Schizophrenia Bulletin, vol.12, issue.1, pp.52-73, 1986. ,
DOI : 10.1093/schbul/12.1.52
A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology, BMC Medicine, vol.142, issue.Suppl, pp.1-22, 2004. ,
DOI : 10.1093/oxfordjournals.aje.a117645
Adult Schizophrenia Following Prenatal Exposure to an Influenza Epidemic, Archives of General Psychiatry, vol.45, issue.2, pp.189-92, 1988. ,
DOI : 10.1001/archpsyc.1988.01800260109013
Serologic Evidence of Prenatal Influenza in the Etiology of Schizophrenia, Archives of General Psychiatry, vol.61, issue.8, pp.774-80, 2004. ,
DOI : 10.1001/archpsyc.61.8.774
Schizophrenia After Prenatal Exposure to the Dutch Hunger Winter of 1944-1945, Archives of General Psychiatry, vol.49, issue.12, pp.983-991, 1992. ,
DOI : 10.1001/archpsyc.1992.01820120071010
Schizophrenia After Prenatal Famine, Archives of General Psychiatry, vol.53, issue.1, pp.25-31, 1996. ,
DOI : 10.1001/archpsyc.1996.01830010027005
The Dutch Famine and schizophrenia spectrum disorders, Social Psychiatry and Psychiatric Epidemiology, vol.33, issue.8, pp.373-382, 1998. ,
DOI : 10.1007/s001270050068
Conclusions, British Journal of Psychiatry, vol.170, issue.04, pp.334-341, 1997. ,
DOI : 10.1192/bjp.170.4.334
Rhesus Incompatibility as a Risk Factor for Schizophrenia in Male Adults, Archives of General Psychiatry, vol.53, issue.1, pp.19-24, 1996. ,
DOI : 10.1001/archpsyc.1996.01830010021004
Obstetric factors, urbanization and psychosis, Schizophrenia Research, vol.43, issue.2-3, pp.117-140, 2000. ,
DOI : 10.1016/S0920-9964(99)00152-8
Schizophrenia and public health. WHO, Division of Mental Health and Prevention of Substance Abuse, 1996. ,
Effects of Psychotherapy in Schizophrenia: II. Comparative Outcome of Two Forms of Treatment, Schizophrenia Bulletin, vol.10, issue.4, pp.564-98, 1984. ,
DOI : 10.1093/schbul/10.4.564
Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy, Psychological Medicine, vol.32, issue.05, pp.763-82, 2002. ,
DOI : 10.1017/S0033291702005895
Psychological treatments in schizophrenia: II. Meta-analyses of randomized controlled trials of social skills training and cognitive remediation, Psychological Medicine, vol.32, issue.05, pp.783-91, 2002. ,
DOI : 10.1017/S0033291702005640
The Expert Consensus Guideline Series. Treatment of Schizophrenia 1999, J. Clin. Psychiatry, vol.60, issue.11, 1999. ,
Pratice Guidelines for the Treatment of Patients with Schizophrenia. Part A: Treatment Recommandations for Patients with Schizophrenia, 2008. ,
Observance médicamenteuse et psychiatrie, Paris, 2004. ,
Long-Term Compliance, Physical Therapy, vol.65, issue.12, pp.1832-1841, 1985. ,
DOI : 10.1093/ptj/65.12.1832
Assessing Patients' Capacities to Consent to Treatment, New England Journal of Medicine, vol.319, issue.25, pp.1635-1643, 1988. ,
DOI : 10.1056/NEJM198812223192504
Clinique, éthique et mutations sociales, Inform. Psychiatr, vol.74, issue.1, pp.47-56, 1998. ,
R??gion des Laurentides : Les habitudes de consommation de psychotropes chez les personnes ??g??es, Sant?? mentale au Qu??bec, vol.21, issue.1, pp.291-295, 1996. ,
DOI : 10.7202/032392ar
URL : http://www.erudit.org/fr/revues/smq/1996-v21-n1-smq1826/032392ar.pdf
Entre compliance et liberté : le témoignage d'un patient, Encephale, vol.25, issue.6, pp.667-71, 1999. ,
Assessment of non-compliance in schizophrenia, J. Pract. Psy. Behav. Health, vol.3, issue.1, pp.106-116, 1997. ,
La souffrance de l'homme. Luçon : Albin Michel, 1996. ,
Compliance issues in primary care, J. Clin. Psychiatry, vol.57, issue.7, pp.76-82, 1996. ,
La compliance : du point de vue du patient, Inform. Psychiatr, vol.14, issue.10, pp.1017-1037, 1998. ,
Medication adherence failure in schizophrenia: a forensic review of rates, reasons, treatments and prospects, J. Am. Acad. Psychiatry Law, vol.27, issue.3, pp.426-470, 1999. ,
Psychiatric patients' attitudes about medication and factors affecting non-compliance, Psychiatr. Serv, vol.48, pp.82-87, 1997. ,
Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings, Schizophrenia Bulletin, vol.23, issue.4, pp.637-51, 1997. ,
DOI : 10.1093/schbul/23.4.637
Awareness of Illness in Schizophrenia and Outpatient Treatment Adherence, The Journal of Nervous and Mental Disease, vol.184, issue.11, pp.653-662, 1996. ,
DOI : 10.1097/00005053-199611000-00001
Drug information on mindinfoline, Open Mind, vol.82, pp.6-7, 1995. ,
Early intervention in schizophrenia: Theoretical background and clinical strategies, British Journal of Clinical Psychology, vol.31, issue.3, pp.257-78, 1992. ,
DOI : 10.1111/j.2044-8260.1992.tb00994.x
The Myriad Medication Mistakes in Psychiatry: A Consumer's View, Psychiatric Services, vol.41, issue.9, pp.993-1001, 1990. ,
DOI : 10.1176/ps.41.9.993
Neuroleptic Intolerance, Schizophrenia Bulletin, vol.23, issue.4, pp.567-82, 1997. ,
DOI : 10.1093/schbul/23.4.567
URL : https://academic.oup.com/schizophreniabulletin/article-pdf/23/4/567/5252374/23-4-567.pdf
The Pharmacologic Treatment of Neuroleptic-Induced Akathisia, Journal of Clinical Psychopharmacology, vol.10, issue.1, pp.12-21, 1990. ,
DOI : 10.1097/00004714-199002000-00003
A review of 32 cases of tardive dystonia, Am. J. Psychiatry, vol.148, pp.1055-1064, 1991. ,
Thérapeutique Médicamenteuse des Troubles Psychiatriques de l'Adulte. Paris : Flammarion, 1996. ,
A Prospective, Multicenter Study of Patients' Refusal of Antipsychotic Medication, Archives of General Psychiatry, vol.47, issue.10, pp.949-56, 1990. ,
DOI : 10.1001/archpsyc.1990.01810220065008
Serum Leptin and Triglyceride Levels in Patients on Treatment With Atypical Antipsychotics, The Journal of Clinical Psychiatry, vol.64, issue.5, pp.598-604, 2003. ,
DOI : 10.4088/JCP.v64n0516
Diabetes mellitus in schizophrenic patients, Comprehensive Psychiatry, vol.37, issue.1, pp.68-73, 1996. ,
DOI : 10.1016/S0010-440X(96)90054-1
A review of the effect of atypical antipsychotics on weight, Psychoneuroendocrinology, vol.28, pp.83-96, 2003. ,
DOI : 10.1016/S0306-4530(02)00114-2
New atypical antipsychotic medications, Journal of Psychiatric Research, vol.32, issue.3-4, pp.3-4215, 1998. ,
DOI : 10.1016/S0022-3956(98)00023-5
Neuroleptiques à action prolongée, Dictionnaire des neuroleptiques, pp.243-248, 1989. ,
L'étude des concentrations des neuroleptiques à action prolongée dans le traitement des psychoses chroniques, Sem. Hop. Paris, vol.60, pp.929-962, 1985. ,
Drug Prescribing for Schizophrenic Out-patients on Depot Injections, British Journal of Psychiatry, vol.156, issue.06, pp.827-861, 1990. ,
DOI : 10.1192/bjp.156.6.827
Guidelines for depot antipsychotic treatment in schizophrenia, European Neuropsychopharmacology, vol.8, issue.1, pp.55-66, 1998. ,
DOI : 10.1016/S0924-977X(97)00045-X
Rispéridone : de la pharmacologie à la clinique, La lettre du pharmacologue, vol.11, issue.10, pp.32-44, 1997. ,
Risperidone long-acting injection, Expert Review of Neurotherapeutics, vol.32, issue.4, pp.435-481, 2003. ,
DOI : 10.1016/S0022-3956(97)00013-7
Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia, Schizophrenia Research, vol.70, issue.1, pp.91-100, 2004. ,
DOI : 10.1016/j.schres.2003.11.001
Pharmacokinetic profile of long-acting injectable risperidone at steady-state : comparison with oral administration, L'Enc??phale, vol.31, issue.5, p.229, 2004. ,
DOI : 10.1016/S0013-7006(05)82420-0
Risperidone injectable LP:modifications du RCP minimes au regard des risques, Rev. Prescrire, vol.26, issue.278, p.815, 2006. ,
Treatment of Schizophrenia With Long-Acting Injectable Risperidone, The Journal of Clinical Psychiatry, vol.64, issue.10, pp.1250-1257, 2003. ,
DOI : 10.4088/JCP.v64n1017
Long-Acting Injectable Risperidone: Efficacy and Safety of the First Long-Acting Atypical Antipsychotic, American Journal of Psychiatry, vol.160, issue.6, pp.1125-1132, 2003. ,
DOI : 10.1176/appi.ajp.160.6.1125
Injections of Depot Antipsychotic Medications in Patients Suffering From Schizophrenia, The Journal of Clinical Psychiatry, vol.62, issue.11, pp.855-864, 2001. ,
DOI : 10.4088/JCP.v62n1104
The Expert Consensus Guideline Series. Optimizing pharmacologic treatment of psychotic disorders. Introduction : methods, commentary, and summary, J Clin Psychiatry, vol.64, issue.12, pp.5-19, 2003. ,
Long-Acting Risperidone, CNS Drugs, vol.12, issue.5, pp.113-132, 2004. ,
DOI : 10.2165/00023210-200418020-00005
Vocabulaire de santé mentale. Paris : Editions de santé, 2006. ,